
Mayo Clinic acquires equity stake in rapid COVID test-maker Genomadix
Ottawa startup awaiting regulatory approval for portable device says partnership with world-renowned U.S. research facility will help further develop its technology.
Mayo Clinic acquires equity stake in rapid COVID test-maker Genomadix
Ottawa startup awaiting regulatory approval for portable device says partnership with world-renowned U.S. research facility will help further develop its technology.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
Tips for home buyers purchasing in a seller’s market
TFSA or RRSP…that is the question!
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.